Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Use of Social Media and Mobile Technology as Essential Tools for EHE
Strategies to engage hard-to-reach youth and young adults through use of social media and related technologies.Resource updated 03/15/2023
-
Performance Measurement: Using Data to Achieve EHE Goals
The use of performance measures to help achieve EHE plan goals.Resource updated 04/07/2023
-
Online Course on Integrated Planning
-
Ending the HIV Epidemic through Innovations in Rapid ART
Review of innovative Rapid ART strategies in diverse settings.Resource updated 03/15/2023
-
Medical Monitoring Project 2019-2020 Data on HIV Care Access and Health Outcomes
In the U.S., almost all people with HIV have some type of health insurance coverage (pub
News Article updated on 08/09/2021 -
Stay Undetectable Poster Series
Consumer-friendly poster series to spark consumers and providers to discuss treatment as prevention and use of their health coverage to support it.Resource updated 10/19/2023
-
Reflections on COVID-19 Driven Telehealth Implementation in the RWHAP
The HRSA white page Innovation and Resilience: How Ryan White HIV/AIDS Program Recipients Leverage Telehealth during the COVID-19 Pandemic offers lessons for future service delivery.Blog updated 01/23/2023
-
Building Partnerships for Data Sharing to Support EHE Plans
Review of building data partnerships with agencies that manage and control access to data, which can support planning and evaluation of EHE activities.Resource updated 04/07/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023
-
Cases From the Clinic(ians): Antiretroviral Therapy Cases and Panel Discussion
Insights for clinicians on selecting antiretroviral therapy and/or managing patients who: are starting initial therapy; are Elite Controllers; have InSTI-associated weight gain; have persistent low-level viremia; have a discordant CD4+ count response to ART; have ‘Blips’; and/or are aging.Resource (Conference Presentation) updated 04/08/2024
-
Transgender Women Engagement and Entry to Care (T.W.E.E.T): E2i
T.W.E.E.T. aims to engage transgender women in HIV care by combining weekly peer-based education and discussion groups, leadership training, community building, and the provision of supportive services. Three sites implemented T.W.E.E.T. as part of E2i, an initiative funded by the RWHAP Part F SPNS program from 2017–2021. Clients had improved outcomes across the HIV care continuum 12 months after enrollment in T.W.E.E.T.Resource from the RWHAP Best Practices Compilation updated on 02/09/2024
-
Imagine: Ending HIV. It’s Possible.
Imagine: Ending HIV. It’s Possible. is TAP-in's national campaign to inspire the HIV workforce to end the HIV epidemic by reducing the number of new HIV infections by 90% by 2030.Resource updated 04/25/2024
-
Long-Acting Injectable ART: Coverage and Cost-Sharing Considerations
Review of fact sheet on different coverage and cost-sharing considerations for LAI ART across public and private payers.Blog updated 12/22/2022
-
National Monitoring Standards and RWHAP Part B Manual Recipients
This HRSA technical assistance webinar provided a high level overview of updates made to both the National Monitoring Standards (NMS) and the Ryan White HIV/AIDS Program (RWHAP) Part B Manual. Release of the NMS is forthcoming.Resource updated 08/21/2023
-
Imagine: Ending HIV. It’s Possible.
Imagine: Ending HIV. It’s Possible is the name of a new, national campaign to encourage and energize the HIV workforce to achieve the national goal of ending the HIV epidemic.Blog updated 06/30/2022
-
Imagine: Ending HIV. It's Possible.
Kickoff of a national campaign to showcase how RWHAP leaders have been innovating to achieve the goal of ending the HIV epidemic.Resource updated 03/15/2023
-
Curing Hepatitis C among People of Color Living with HIV: Final Report and Apps/Training Tools
Slide summary and apps/training tools from the SPNS initiative, Curing Hepatitis C among People of Color Living with HIV. including: evaluation questions; dissemination activities; and site reports.Resource updated 05/15/2024
-
Long-Acting Injectable Antiretroviral Therapy: Coverage and Cost-Sharing Considerations for RWHAP Clients
Fact sheet on the different coverage and cost-sharing considerations for LAI ART across public and private payers.Resource updated 09/19/2023